EUVIMEDEUVIMED entdecken
Crossref

Qishen Yiqi dripping pills alleviate myocardial ischemia–reperfusion-induced fibrotic injury by inhibiting fibroblast activation via the transforming growth factor-beta/Periostin pathway

Teng Ge, Jinlin Hu, Baiqing Lin, Liangbin Yang, Bo Ning, Jingyu Bo, Jiaxin Ju, Kunyang He, Guanmou Li, Chaojie Wang, Rongjun Zou, Hongfei Qi und 1 weitere

Journal of Ethnopharmacology · 2026-11 · 370 · 122012

DOI: 10.1016/j.jep.2026.122012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026-11. Verfasst von Teng Ge und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China; Department of Cardiovascular Surgery, Guangdong Pr…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Myocardial Reperfusion Injury, Transforming Growth Factor beta, Fibroblasts. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Natural Science Basic Research Program of Shaanxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE Qishen Yiqi Dripping Pills (QSYQ), composed of Astragalus membranaceus Fisch. ex Bunge, Salvia miltiorrhiza Bunge, Panax notoginseng (Burkill) F.H.Chen, Dalbergia odorifera T.C.Chen have been included in the Pharmacopoeia of the People's Republic of China and are known to alleviate myocardial ischemia-reperfusion injury. However, whether QSYQ regulates transforming growth factor-beta (TGF-β)/Periostin (Postn) signaling to inhibit fibroblast activation remains unclear. AIM OF THE STUDY Pathological repair following myocardial ischemia-reperfusion injury (MIRI) is driven by the TGF-β/Postn signaling axis. Targeted modulation of this process may represent a potential pathway for antifibrotic therapy. In this study, we integrated multi-omics analyses with experimental validation to systematically elucidate that QSYQ reverses fibroblast activation by targeting the TGF-β/Postn axis, thereby ameliorating fibrotic remodeling associated with MIRI. Materials and Methods BIOINFORMATICS ANALYSIS: By integrating single-cell and transcriptomic data, along with network pharmacology and Least Absolute Shrinkage and Selection Operator (LASSO), potential targets of QSYQ against MIRI were identified. Molecular dynamics simulations were then employed to predict the binding affinity between QSYQ components and these potential targets. EXPERIMENTS In vivo, C57BL/6N mice orally received QSYQ before MIRI surgery. Cardiac function was assessed by echocardiography and cTnT, myocardial pathology by Masson staining, the protein levels of TGF-β/Postn and the expression of Alpha smooth muscle actin (α-SMA) and Collagen Type I alpha 1 Chain (COL1A1) were assessed by immunofluorescence or Western blotting. In vitro, HL-1 cells were treated with QSYQ-containing serum; cytotoxicity was measured by Cell Counting Kit-8 (CCK-8), and the effect on SRI-011381 intervention was evaluated. RESULTS Single-cell sequencing and transcriptomic data indicated that activated fibroblasts were significantly increased after MIRI, and that Postn serves as a potential target driving the transition of fibroblasts toward an activated phenotype. Network pharmacology and molecular dynamics simulations further demonstrated that the circulating components of QSYQ, Calycosin-7-O-β-D-glucoside and Notoginsenoside R2, exhibit favorable binding affinities for both TGF-β and Postn. In vivo and in vitro experiments confirmed that QSYQ improves cardiac function, alleviates pathological myocardial injury, and reduces the protein expression levels of TGF-β, Postn, α-SMA, and COL1A1 following MIRI. CONCLUSION The alleviation of fibrosis by QSYQ following MIRI may be associated with the regulation of the TGF-β/Postn signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalMyocardial Reperfusion InjuryTransforming Growth Factor betaFibroblastsAnimalsFibrosisSignal TransductionMaleMice, Inbred C57BLPeriostinMiceNetwork Pharmacology

Stichwörter der Autor:innen

Fibroblast activationMulti-omics analysisQishen Yiqi dripping pillsSingle-cell sequencing

Substanzen

Drugs, Chinese HerbalTransforming Growth Factor betaqishen yiqiPeriostin

Autor:innen und Institutionen

  • The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China; Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital…
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China. Electronic address: 18846926465@163.com.
  • Second Clinical School, Southern Medical University, Guangzhou, Guangdong, 510280, China. Electronic address: lgmgdmm@i.smu.edu.cn.
  • College of Integrated Traditional Chinese and Western Medicine, Shaanxi University of Chinese Medicine, Xi'an, Shaanxi, 712046, China. Electronic address: qihongfei@mail.nwpu.edu.cn.

Förderung

  • Natural Science Basic Research Program of Shaanxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Ge, T., Hu, J., Lin, B., Yang, L., Ning, B., Bo, J., Ju, J., He, K., Li, G., Wang, C., Zou, R., Qi, H., & Fan, X. (2026). Qishen Yiqi dripping pills alleviate myocardial ischemia–reperfusion-induced fibrotic injury by inhibiting fibroblast activation via the transforming growth factor-beta/Periostin pathway. Journal of Ethnopharmacology, 370, 122012. https://doi.org/10.1016/j.jep.2026.122012

Vancouver

Ge T, Hu J, Lin B, Yang L, Ning B, Bo J, et al. Qishen Yiqi dripping pills alleviate myocardial ischemia–reperfusion-induced fibrotic injury by inhibiting fibroblast activation via the transforming growth factor-beta/Periostin pathway. Journal of Ethnopharmacology. 2026;370:122012. doi:10.1016/j.jep.2026.122012

BibTeX
@article{Ge2026,
  author = {Ge, Teng and Hu, Jinlin and Lin, Baiqing and Yang, Liangbin and Ning, Bo and Bo, Jingyu and Ju, Jiaxin and He, Kunyang and Li, Guanmou and Wang, Chaojie and Zou, Rongjun and Qi, Hongfei and Fan, Xiaoping},
  title = {Qishen Yiqi dripping pills alleviate myocardial ischemia–reperfusion-induced fibrotic injury by inhibiting fibroblast activation via the transforming growth factor-beta/Periostin pathway},
  journal = {Journal of Ethnopharmacology},
  year = {2026},
  volume = {370},
  pages = {122012},
  doi = {10.1016/j.jep.2026.122012}
}
Kostenlos starten →